Dr. McLaws obtained his Ph.D. from the University of Utah and has over 19 years of process chemistry experience in the pharmaceutical manufacturing industry. During his career, he has supported process development and manufacturing of clinical-phase and commercial small molecule APIs in a variety of therapeutic areas. At Asymchem, Dr. McLaws leads a team of technical experts to support CMC activities, with a particular focus on late-stage development, validation, and commercialization.